"Lack of Understanding of Genetic Breast Cancer Testing" - Kate Johnson
A lack of understanding among clinicians about genetic information is contributing toward the unnecessary use of bilateral mastectomies (BLMs), say researchers. In an accompanying editorial, Soojin Ahn, MD, and Elisa R. Port, MD, from Mount Sinai Health System, write, “Because most VUSs [variants of uncertain significance] are ultimately reclassified as benign, the management of an individual who carries a VUS should be based on personal and family history and not on the presence or absence of the variant itself.”
- Soojin Ahn, MD, Assistant Professor, Surgery, Icahn School of Medicine at Mount Sinai
- Elisa Port, MD, FACS, Associate Professor, Surgery, Icahn School of Medicine at Mount Sinai, Chief, Breast Surgery, Co-Director, Dubin Breast Center, The Mount Sinai Hospital
Future Breast Imaging and Biopsy Are Not Eliminated After Mastectomy
Oct 09, 2018 View All Press Releases